Scientific Programme

Download Programme Day 1     Download Programme Day 2     Download Programme Day 3     Download Programme Day 4

09:00 - 10:00
New Kids on the Block

9.00-9.09  Antihyperkalemics Agents
9.09- 9.18 New PAH Therapies
9.18-9.27  Antidotes for DOACs
9.27-9.36  Newer ARBs & CCBs
9.36-9.45  Newer Antidyslipidemics: PCSK9 Inhibitors, siRNA Inhibitor
9.45-9.54  Anti-Obesity agents
9.54-10.00 Discussion and Audience Interaction

10:00 - 11:00
Controversies in Cardiology - Is there a Consensus?

10.00-10.09  Digitalis in HF - Is there an Indication Left?
10.09- 10.18  68 year old male with No Risk Factors : Should a Calcium Score be done for Risk Stratification? 
10.18-10.27  Vaccination in Cardiovascular Disease - Is it for All?
10.27-10.36  Should an Angiogram be done in all patients of STEMI presenting after 3 days?
10.36-10.45  Should Non Fasting Lipid Profile be the Standard of Care?
10.45-10.54  Is Hydrochorthiazide being Pushed to Oblivion? Right or Wrong
10.54-11.00  Discussion and Audience Interaction

11:00 - 12:00
Lipidology - An Overview for the Clinician

11.00-11.09  Lipid Guidelines: An Overview
11.09- 11.18 Treating High Triglycerides: Reducing CV Risk or a Mere Cosmetic Reduction
11.18-11.27  LDL Levels: How Low is Low Enough?
11.27-11.36  Chossing between Statins: Personal Preference or Rational Choice
11.36-11.45  Non Statin alternatives for Lipid Management: An Overview
11.45-11.54  Diabetic Dyslipidemia - Is it a Distinct Entity?
11.54-12.00  Discussion and Audience Interaction

12:00 - 13:00
Prevention of CAD - Striving to Make it a Reality

12.00 -12.10 CV Risk Scores: Which one is Ideal for Indians?
12.10 -12.20 Early detection of CVD: Why, When and How
12.20 -12.30 Targetting CV Risk: Novel Risk factors and New Therapies
12.30 -12.40 Primary Prevention of CVD  in Diabetics
12.40 -12.50 Diet and Exercise Prescription for CAD
12.50 -13.00  Discussion and Audience Interaction

13:00 - 14:00
Stable CAD - More Questions than Answers

13.00 -13.10 Incidental CAD on Routine CT Angio: How to Proceed 
13.10 -13.20 Ischemia Testing for Stable CAD: Role and Relevance 
13.20 -13.30 Medical Therapy for CAD: What is  "Optimal"
13.30 -13.40 Refractory Angina: Therapeutic Approaches
13.40 -13.50 Angina with Normal Epicardial Coronary Arteries: What should we do? 
13.50 -14.00 Discussion and Audience Interaction

14:00 - 15:00
Heart Failure Care - Simplified

14.00 - 14.10 Diagnosis and evaluation of a patient with suspected HF: Step Wise Approach
14.10 - 14.20 Biomarkers in Heart Failure: When to order and How to Interpret
14.20 - 14.30 Acute decompensated HF: An Internist’s Approach 
14.30 - 14.40 Treating HFrEF: ARNI  vs ACEI/ARBs -Which will be My Choice in Indian context?  
14.40 - 14.50 Cardiorenal Syndrome in  Heart Failure: A Pragmatic Approach
14.50 - 15.00 Discussion and Audience Interaction

15:00 - 16:00
Advanced Heart failure - Therapeutics

15.00 - 15.10 Heart Failure with Preseved EF: Diagnosis and Treatment
15.10 - 15.20 Anemia/ Iron deficiency and Heart Failure
15.20 - 15.30 ICD and CRT in HF - Current status
15.30 - 15.40 Devices to Support the Failing Heart: ECMO, LVAD and Tandem Heart
15.40 - 15.50 Heart Failure Clinics: Integral for a HF Program
15.50 - 16.00 Discussion and Audience Interaction

16:00 - 17:00
Hypertension - The Silent Killer

16.00 - 16.10 ACC Vs ESC Guidelines for Hypertension: Which fits Best in Indian Scenario?
16.10 - 16.20 First line Hypertensives: Which  Drug and Why? 
16.20 - 16.30 Managing Hypertension in Acute Stroke 
16.30 - 16.40 When and How to Screen for Secondary Hypertension
16.40 - 16.50 Managing Resistant Hypertension: Problems and Solutions
16.50 - 17.00 Discussion and Audience Interaction

17:00 - 17:45
Focused session :Learn with the Masters

  • Contemporary Management of Chronic Heart Failure:Optimal use of  Traditional and Newer drugs.
  • TBA
  • TBA
  • Discussion and Audience Interaction

17:45 - 18:30
Focused Session :Learn with the Masters

  • Cardiovascular Disease in Chronic Kidney Disease
  • How Useful is Echo in the Assessment and Management of Functional MR  
  • General Overview of Diagnosis and Management of Hypertrophic Cardiomyopathy
  • Discussion and Audience Interaction

09:00 - 10:00
Cath Lab Practicals: Beginners Boot Camp - Session I: Basic about My Tool Box

  • Radial Access: Tips and Tricks
  • Chosing the Optimal Coronary Guidecatheter 
  • Chosing the Correct Coronary Guidewire
  • Choosing between Coronary Angioplasty Balloons
  • Coronary Stent Selection
  • Discussion and Audience Interaction

10:00 - 11:00
Cath Lab Practicals: Beginners Boot Camp - Session II: Techniques

  • When to POT and How to Do it
  • Bifurcation Techniques for the Beginners
  • Primary PCI: Do`s and  Don’t`s
  • FFR and IFR - Practical Aspects
  • Discussion and Audience Interaction

11:00 - 12:00
CSI's Got Talent: Challenging Case Presentations

Case 1 - Discussion and Audience Interaction
Case 2 - Discussion and Audience Interaction
Case 3 - Discussion and Audience Interaction
Case 4 - Discussion and Audience Interaction
Case 5 - Discussion and Audience Interaction
Case 6 - Discussion and Audience Interaction
Case 7 - Discussion and Audience Interaction
Case 8 - Discussion and Audience Interaction

12:00 - 13:00
Meet the Legends: Session I- What I Always Wanted to Know But Didn’t Know Whom to Ask

  • CTO - Antegrade to Retrograde Approach: Tips for Beginners
  • High Risk PCI : Do`s & Don`ts 
  • Left Main Interventions – Techniques to Use  in 2018
  • Graft Intervention - Tips and Tricks
  • Discussion and Audience Interaction

13:00 - 14:00
When Your Worst Nightmares Come True

  • Coronary Perforation - When and How to Seal the leak?
  • Thrombus Formation during PCI: What to Do?
  • Malignant Slow Flow or No Reflow on the Table - What Next?
  • Acute Hypotension with Pallor after a Successful PCI: What to do?
  • Stent Dislodgement : Bailout Steps and Techniques
  • Discussion and Audience Interaction

14:00 - 15:00
Meet the Legends: Session II - What I Always Wanted to Know But Didn’t Know Whom to Ask

  • Assessing Coronary Physiology Before Resvacularization: Current Concepts
  • IVUS and OCT : Role and Relevance in PCI
  • New Devices for Debulking & Lesion Preparation: Tips & tricks
  • Managing True Bifurcation Lesions
  • Discussion and Audience Interaction

15:00 - 16:00
Meet the Legends: Session III - What I Always Wanted to Know But Didn’t Know Whom to Ask

  • Carotid Intervention – When and How: The Masters Approach
  • Transcatheter Aortic Valve Replacement: Tips and Tricks
  • Tips and Tricks in Alcohol Septal Ablation 
  • Optimising Coronary Stenting: Do`s & Don’t`s
  • Discussion and Audience Interaction

16:00 - 17:00
CTO Workshop

  • Case Selection for CTO PCI: Choosing cases wisely
  • Angiogram Performance and Evaluation for the CTO Operator: Proximal Cap, Distal Cap, Lesion Length, and Collateral Assessment
  • Wire Selection and Basic Principles for Wire Manipulation  for Antegrade Approach
  • CTO Antegrade Reentry Techniques
  • Balloon Uncrossable CTO Lesion: What Next ?
  • Discussion and Audience Interaction

17:00 - 18:00
My Worst Complication : Lessons Learnt

5.00 - 5.10 Radial Artery Access Complication
5.10 - 5.20 Left Main Disaster
5.20 - 5.30 Abrupt Vessel Closure
5.30 - 5.40 Burr Entrapment during Rotablation
5.40 - 5.50 Broken Balloons / Wires
5.50 - 6.00 Discussion and Audience Interaction

09:00 - 10:00
Imaging in CHD - Taking a Deeper Look

  • Comprehensive Echocardiograpic Assessment of a VSD
  • ASD : To Device or Not? An Echo Guide
  • Common Mistakes to Avoid in CHD Echocardiography
  • CT Angiography in CHD - Is it Worth the Radiation?
  • Cardiac MRI in CHD - An Update
  • Discussion and Audience Interaction

10:00 - 11:00
Bread and Butter Pediatric Cardiology

  • VSD - Natural History and When to Intervene
  • ASD Device closure - Tips and Tricks
  • Difficult PDAs for Device Closure - How to Identify and Succeed
  • Vascular Access in Children - Tips and Tricks
  • Difficult AVBD and PVBD
  • Discussion and Audience Interaction

11:00 - 12:00
Interventional Pediatric Cardiology - Expanding Horizons

  • VSD Device Closure - Is it Ready for Prime Time?
  • RSOV Device Closure - Patient Selection and Tricks
  • Coarctation in Adults - Should I Stent All?
  • Palliative Interventions in Cyanotic CHD
  • Transcatheter Pulmonary Valve Implantation: An Update
  • Discussion and Audience Interaction

12:00 - 13:00
Adults with CHD - The GUCH Group

  • The 'Totally Corrected' TOF: How to Follow Up?
  • Living with Fontan
  • CTGA: Approach to Management
  • Ebsein's Anomaly - A Contemporary Update
  • Adult CHD Guidelines - What is New?
  • Discussion and Audience Interaction

13:00 - 14:00
Extracting the most from the 12 lead ECG: ECG interpretation made easy

  • ECG in Supraventricular Tachycardia: Basics and Beyond
  • Wide Complex Tachycardia: Small clues in a Broad Rhythm
  • AV Block: ECG Recognition and Localization
  • Beyond ST Elevation: ECG patterns for ACS
  • ECG in Dyselectrolytemia and Repolarization Syndromes 

14:00 - 15:00
Follow Up of Implantable Devices: Physicians Guide Book

  • Pacemaker Troubleshooting: What every Phycian needs to Know
  • CRT: What to Program to Optimize Outcomes
  • Inappropriate Shocks with ICDs: Recognition, Programming and Prevention 
  • Routine Home (Remote) Monitoring: An Idea Whose Time Has Come?
  • My Pacemaker Dependent Patient has a Non Conditional ICD: Can he Undergo an MRI? 
  • Discussion and Audience Interaction

15:00 - 16:00
Controversies in Rhythm Management: How Will I Manage

  • Paroxysmal AF: Drugs or Ablation?  
  • Sick Sinus Syndrome : When to Wait and When to Pace
  • Frequent PVCs and Near Normal EF: How to Proceed?
  • 50  years old with prior MI with Recurrent Stable Monomorphic  VT: Why, When & How to ablate? 
  • Bifascicular Block: When to Pace?
  • Discussion and Audience Interaction

16:00 - 17:00
Arrhythmia Potpourri: Physician Dilemmas

  • Managing  an Implantable Device during MRI, Radiotherapy and Non-Cardiac Surgery
  • My patient with Congenital CHB presents in the First Trimester of Pregnancy: To Pace or Not To Pace? 
  • Patient with CRT-D near ERI whose LVEF has Recovered: What now?
  • My patient with Recurrent CHF has Non LBBB Morphology: Do I suggest CRT? 
  • Prescribing Amiadarone : Practical Do`s and Don’t`s
  • Discussion and Audience Interaction

17:00 - 18:00

  • Early Repolarization: When is it Abnormal?
  • ARVC: Diagnostic Challenges
  • Brugada syndrome: Diagnosis and Risk Stratification
  • Long QT Syndrome: Diagnosis and Risk Assessment
  • Unmasking Channelopathies: Role of Provocation Tests
  • Role of ICD and Ablation in Patients with Inherited Arrhythmic Syndromes

09:00 - 10:00

  • Cardiac CT: The Crystal Ball of Truth. One stop shop: Plaque, Stenosis, Ischemia, Viability and FFR 
  • Cardiac MRI conquers IHD and viability 
  • Cardiac MRI: The Critical Piece in the Puzzle for NICMP
  • Imaging in TAVR: All I Need to Know
  • Discussion and Audience Interaction

10:00 - 11:00
Day to Day Echocardiography

  • Echocardiography in the Emergency
  • Mistakes to Avoid in LVEF Assessment
  • Diastology - Simplified
  • Assessing Individual Valve Lesion Severity in Multivalvular Heart Disease
  • Assessing the Right Ventricle
  • Discussion and Audience Interaction

11:00 - 12:00
Advances in Echocardiography

  • 3D Echocardiography - Utility or Futility?
  • Integrating Strain Imaging in my Echo practice
  • Stress Perfusion Echocardiography - Is it Ready for Prime Time?
  • Interventional Echocardiography and Echo-Navigation
  • Fetal Echo: State of the Art
  • Discussion and Audience Interaction

12:00 - 13:00
CT/MRI Case based Discussion

  • Case 1: Post Intervention Chest Pain
  • Discussion and Audience Interaction
  • Case 2: CMR in VT 
  • Discussion and Audience Interaction
  • Case 3: CMR in Hypertrophic CMP
  • Discussion and Audience Interaction
  • Case 4:CMR in Heart Failure
  • Discussion and Audience Interaction
  • Case 5: Restrictive CMP
  • Discussion and Audience Interaction
  • Case 6:Constrictive pericarditis
  • Discussion and Audience Interaction
  • Case 7: CMR Quantification of MR
  • Discussion and Audience Interaction
  • Case 8:RV : The Forgotten Chamber
  • Discussion and Audience Interaction

13:00 - 14:00
Focussed Learning

  • Transesophageal Echo in Endocarditis
  • Stress Echocardiography - Pitfalls to Avoid
  • Making the best use of Contrast Echo
  • Prosthetic Valve Thrombosis: Is it Mandatory to do TEE
  • Mitral Regurgitation: Assessing the Mechanism
  • Aortic Stenosis: Evaluationg Low-Flow Low-Gradient AS
  • Prosthetic Valve Function: What is Normal and What is Not?

14:00 - 15:00
Meet the Masters

  • Pitfalls in Echo Assessment of Valvular Regurgitation and How to Avoid Them
  • Role of Advanced Imaging in Evaluation of Cardiomyopathies
  • TBA
  • Echocardiographic Assessment of RV Function

15:00 - 15:45
Navin C. Nanda Young Investigator Award

Presenter 1
Discussion and Audience Interaction
Presenter 2
Discussion and Audience Interaction
Presenter 3
Discussion and Audience Interaction

15:45 - 17:00
Echo Pearls

  • Relax with Diastology
  • Constriction and Restriction
  • Lung Ultrasound
  • RWMA but no CAD
  • Masquerades of Vegetation
  • ASD with Cyanosis
  • Cardiac Tumors

17:00 - 18:00
My Best Echo Case- Straight from the Masters

Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7

09:00 - 10:00
CAD Pathophysiology

  • Rsik Factors for Atherothrombosis - Beyond the Traditional Markers
  • Is Athersosclerosis an Inflammatory Disease?
  • Vulnearbale Plaque or Patient - Is it worth Chasing?
  • ACS: Erosion or Plaque Rupture – Does it make a Difference
  • Regressing Atherosclerosis - WilI it be a Reality?
  • Discussion and Audience Interaction

10:00 - 11:00
ACC@CSI- From ER to Interventions

  • Encounter with the Chest Pain Patient in the ER: Gleaning Wheat from Chaff 
  • Role of High Sensitivity Troponins: Have We Found the Desired Biomarker 
  • Universal Definition of Acute Coronary Syndromes and its Risk Stratification : Virtues and Shortcomings 
  • STEMI Care in LMICs: Need for Establishing Superior System of Care
  • Discussion and Audience Interaction

11:00 - 12:00
Plenary Session

11.00 -11.15 The Mystery of HDL and Cardiovascular Risk
11.15 -11.30 Diabetes and CVD: The Clincal Importance of Cardiovascular Outcome Trials with New Drugs 
11.30 -11.45 TBA
11.45 -12.00 TBA

12:00 - 13:00
Plenary Session

12.00 - 12.15 Update in Management of Stable CAD: OMT or PCI or CABG
12.15 - 12.30 Revascularizing Stable Angina : Stenosis or FFR?
12.30 - 12.45 Transcatheter Aortic Valve Replacement:  Current Status
12.45 - 13.00 Sudden Death Prevention in HCM:  Risk Stratification Strategy

13:00 - 14:00
Debate : Views and Counterviews

Debate 1 - Is My Practice Right
STEMI Presenting between 24 hours to 48 hours – PCI Still has a Role 
13.00 - 13.12 Pro
13.12 - 13.24 Con
13.24 - 13.26 Rebuttal
13.26 - 13.28 Rebuttal
13.28 - 13.30 Discussion and Audience Interaction
Debate 2: The Cholesterol Controversy 
13.30 - 13.42 It is a Rip Off, We have been Fooled                                                                                    
13.42 - 13.54 Dont Jump to Conclusions, Follow the Evidence
13.54 - 13.56 Pro
13.56 - 13.58 Con
13.58 - 14.00 Rebuttal
Discussion and Audience Interaction

14:00 - 15:30

 14:00-14:30  DAPT After Coronary Intervention
 What is the Optimal Duration: A Guideline Based Approach
 DAPT in Patients Needing Oral Anticoagulants: Current Recommendations
 Discussion and Audience Interaction
14:30-15:00  NSTEMI in Elderly
Challenges of Invasive Approach
Challenges of Pharmacotherapy
Discussion and Audience Interaction
15:00-3:30 Cardiogenic Shock
Cardiogenic Shock: Current State of the Art Management
Optimizing Medical Therapy in Cardiogenic Shock:  A Pragmatic Approach
Discussion and Audience Interaction

15:30 - 16:00
Key Note Address

  • Comprehensive Health Coverage for All: Is the Path Too Long
  • The War Against Heart Failure: Waiting to be Conquered

16:00 - 17:00
Rapid Fire - Red Hot Topics

  • Can Clopidogrel replace Aspirin in stable CAD
  • Beta blockade following STEMI: Changing Times?
  • Statin Induced Diabetes: Unfounded Fears or a Fearsome Foe
  • Insufficient Sleep and Cardiometabolic Risk 
  • Central Blood Pressure - Is it relevant?
  • Carotid stenting- Is there an indication left?
  • Physical activity and obesity paradox in coronary heart disease.

17:00 - 17:45
Plenary Session

  • Secondary Prevention in ACS in 2018
  • Device therapies to prevent sudden cardiac death & improve quality of life in chronic hear failure: Current status and future
  • Antithrombotic therapy for heart failure: an update

09:00 - 10:00
Hypertension Controversies

  • Office, Home or BP on the Move? Which to use for Managing  of Hypertension
  • No ACEI only ARB for Hypertension Management
  • Lowering Dietary Sodium for Hypertension: Yes? No? Maybe? 
  • Improving Management of Hypertension: Is Initial use of Combinations the Solution?
  • Move Beyond the Cuff: Should BP Management be Guided by CVD risk?
  • Device based therapies for hypertension: Current status and future prospects 
  • Discussion and Audience Interaction

10:00 - 11:00
Lipid Masterclass by Experts: A Case Based Approach

  • 50-yr-old Male, Hypertensive, Smoker, LDL 135, HDL 26, TG 94; Zero Calcium Score on CT Angio: Does he need Statins?
  • Discussion and Audience Interaction
  • 47-yr-old Female, Obese, Hypertensive, LDL 150, HDL 44, TG 370. How do I address Lipid goals?
  • Discussion and Audience Interaction
  • 45 year-old asymptomatic male, Family history of ischemic stroke in father with Dyslipidemia - TC 280 LDL 186 TG 98 HDL 44. Displays intolerance to Statins. What to do Next?
  • Discussion and Audience Interaction
  • 78 year old female, Hypertensive, Diabetic, No previous history of CAD admitted for THR. ECG, Echo normal. Needs clerance for surgery. Do we initiate statins to modify cardiac risk?
  • Discussion and Audience Interaction

13:00 - 14:00
Making the Right Choice in Clinical Management

My first choice of DAPT  in CAD                                            
  • Ticagrelor
  • Prasugrel 
  • Clopidogrel 
Discussion and Audience Interaction
  • 60 year old, hypertensive, non-diabetic, asymptomatic, executive check up - on CTA mid LAD 70%, N LV function. My ideal strategy would be
  • Ischemia testing
  • Revascularization
  • Leave him alone on OMT
Discussion and Audience Interaction

14:00 - 15:00
Challenging Cases in Clinical Practice

47 year old male, post Cholecystectomy, develops Chest Pain 48 hours after surgery with rising Troponins and T wave inversions. How will I manage?                                 
Discussion and Audience Interaction
69 year old female known hypertensiive, presented to emergency with altered sensorium, tachycardia and tachypnea. Known CKD (Cr 2,0). TLC 14,540 with shift to left, Trop T 0.57 rising to 3.2 and then decreasing, EKG 1mm HZ ST depression inferolateral leads, Q in III. 
Discussion and Audience Interaction
70 year old male with HTN, OSA presents with STEMI. Undergoes primary PCI to LCx. Develops recurrent episodes of AF in hospital stay - reveals history of AF in past which was untreated. 
Discussion and Audience Interaction
55 year old male, T2DM, HTN presents wth DOE NYHA Class II 3 months duration, No angina; QRS non specific ST-T changes, LVEF 30%, CART: TVD, LAD long calcific CTO; Type A discrete lesion in prox LCx and mid RCA. 
Discussion and Audience Interaction

15:00 - 16:00
ACS - An Overview

  • Diagnosis & Classification of ACS
  • Risk Stratification in ACS
  • Pharmacological Management in NSTE-ACS
  • Revascularization in NSTE-ACS - Modality and Timing
  • Choice of DAPT - Making the right switch
  • Discussion and Audience Interaction

16:00 - 17:00
Devices in Cardiology :Where are We Now and Where are we Heading?

  • Transcatheter Mitral Valve Interventions
  • Transcatheter Tricuspid and Pulmonary Valve Interventions
  • Haemodynamic support during CHIP: Which Device and When? 
  • LAA Device Closure
  • PFO Closure
  • Discussion and Audience Interaction

09:00 - 10:00
Acute Cardiac Care: Practical Tips

  • Takasubo Cardiomyopathy: Recognition and Therapeutic Approach
  • Blunt Cardiac Trauma: What to Tell the Intensivist
  • Acute Aortic Dissection:Diagnosis and Management
  • STEMI with Acute Stroke: What takes Precedence
  • Acute MR: Challenges in Management
  • Choosing Inotropes in Cardiogenic Shock
  • Discussion and Audience Interaction

10:00 - 11:00
VT Conclave

  • VT in the Normal Heart: Benign and Not so Benign
  • Granulomatous VT: Recognition and Therapy
  • Taming a VT Storm: Systematic Approach
  • Discussion and Audience Interaction
  • Debate
  • CRTD for all in LV Dysfunction, No place for CRTP?
  • Pro
  • Con
  • Rebuttal Pro
  • Rebuttal Con

13:00 - 14:00
Infective IE : A Bugs Life

  • Newer modalities for Diagnosing IE: Echo and beyond .
  • Outpatent Treatment of IE: Are you Serious?
  • Cardiac Device Related IE: Management Strategies
  • Surgery for IE
  • Prophylaxis for IE: Current update
  • Discussion and Audience Interaction

14:00 - 15:00
Demystifying Age Old CCU Dilemmas - Simplified Approach

  • HF with Hyponatremia
  • HF Patient with Hyperkalemia
  • Acute MI with DKA
  • ACS with Acute on Chronic Renal Failure
  • Acute Pulmonary Edema with COPD
  • Pregnancy with PHVT
  • Pregnant mother with SVT
  • Discussion and Audience Interaction

15:00 - 16:00

  • CRT Non-responders: A Systematic Approach
  • CRT in Chronic AF: Optimal Strategy
  • Imaging and CRT: Can We Integrate the Two?
  • Optimal Left Ventricular Lead Placement
  • Tips and Tricks for Advanced CRT Programming
  • Discussion and Audience Interaction

16:00 - 17:00
Future in Cardiology: Alice in Wonderland

  • Robotic PCI: Just a Fad?
  • Hand Held Echo: An Idea Whose Time Has Come
  • Remote Monitoring in Cardiology
  • AI in Cardiology
  • mCardiology
  • Drones in Cardiology

09:00 - 10:00
Public Policy and Cardiology

  • Capping Stent Price: Futuristic or Obstructionist
  • Low Price Generics: Pill or Powder
  • Reusing Catheters: Is Consent Enough
  • Patient – Doctor Relationship: How to reverse the fall?
  • Ayushman Bharat : Will It Change our Practice?
  • Violence against Doctors – Preventing this Malaise
  • Discussion and Audience Interaction

10:00 - 11:00
Cardiac surgery

  • Tricuspid valve repair/ replacement: when and how to approach.
  • Complete vs Incomplete Revascularization for TVD: Does it impact outcomes
  • All Arterial CABG: Important Yes, But How Realistic?
  • Port Access / Less Invasive CABG: Current Status
  • Heart transplantation in India - A status report
  • Discussion and Audience Interaction

13:00 - 16:00
Post Graduate Teaching: Session I

  • Bed side Assessment of severity of valvular lesions
  • Interpretation of X ray
  • Approach to an adult presenting with pulmonary hypetension
  • Case 1 : Multivalvular heart disease :
  • Case Presenter

16:00 - 17:00
Post Graduate Teaching: Session II- Hemodynamic

  • Approach to Hemodynamic
  • Hemodynamic spotters

13:00 - 14:00
Oral Poster Presentation

  • Incidence and in-hospital mortality of ventricular septal rupture in ST elevation myocardial infarction.
  • Measurement of coronary artery diameter by IVUS and QCAin Asian-Indian population: study from Tertiary Care Centre of North India.
  • Correlation of QRS duration with myocardial blush grade as a marker of myocardial reperfusion in patients undergoing primary percutaneous coronary intervention.
  • Evaluation of tachycardia independent diastolic microvascular transit time (DMTT) as potential predictor of microvascular dysfunction.
  • Incidence,predictors,clinical profile and outcome of patients with unprotected left main coronary artery angioplasty.
  • Clinical outcome of patients undergoing primary PCI with adjunctive therapy of bivalirudin, heparin alone or heparin with glycoprotein IIb/IIIa inhibitors: a prospective, comparative study.
  • The final frontier- Left main PCI: Analysis from the Sathya Sai CAD registry.

14:00 - 15:00
Oral Poster Presentation

  • Value of resting and stress myocardial deformation assessment by 2 dimensional speckle tracking echocardiography to detect the presence, extent and localization of coronary artery affection in patients with stable coronary artery disease.
  • Prasugrel resistant and impact of select gene variants in Indian patient with coronary artery disease.
  • Alcohol binge- a striking trigger for acute myocardial infarction.
  • Incidence and follow up outcomes of myocardial infarction with non obstructive coronary artery disease entity after pharmacological thrombolysis.
  • Clinical profile and outcomes of patients with recurrent ST elevation myocardial infarction: a prospective observational study.
  • A novel class of parenteral anticoagulant agents for percutaneous coronary intervention (PCI) based on tick thrombin inhibitors.
  • The impact of total arterial revascularisation technique on mortality and morbidity in off-pump redo surgery patients.

15:00 - 16:00
Oral Poster Presentation

  • Analysis of telomere, endotheial dysfunction and mitochondrial DNA damage in diabetes and hypertension patients.
  • Prevalence of hypertension and risk factors among young Indians
  • Barriers for adherence to anti-hypertensive medication among rural women in india: qualitative study.
  • High prevalence of resistant hypertension in india: jaipur heart watch.
  • School-based surveillance for detection of children with acute pharyngitis, rheumatic fever/rheumatic heart disease in shimla district, himachal pradesh, India—a cluster randomized controlled trial.
  • Evaluation of systemic and tissue levels of cytokines of Th17 axis in patients of chronic rheumatic heart disease: an observational study.

16:00 - 17:00
Oral Poster Presentation

  • Right dorsal radial artery approach in an era of Radial artery catheterization for transradial coronary intervention- a single center study observational study.
  • Fighting for a foothold on a slippery slope: the challenge of CTOs with blunt cap and side branch.
  • Comparison of coronary fractional flow reserve using adenosine and contrast as hyperaemic agents.
  • Emergency percutaneous coronary intervention following return of spontaneous circulation in acute coronary syndrome complicated by cardiogenic shock.
  • Study of plaque characteristics in young patients with myocardial infarction using optical coherence tomography (OCT).
  • Immediate percutaneous coronary intervention following return of spontaneous circulation in cardiac arrest due to acute coronary syndrome: single centre experience.
  • Percutaneous transcatheter closure of ruptured sinus of valsalva aneurysm: immediate results and long-term follow-up.

09:00 - 10:00
Heart Failure: Myths, Misconceptions and Reality

  • My patient in NYHA functional class II, is he really stable?
  • MRA in asymptomatic HF
  • Heart rate and BP - Is lower the better in heart failure?
  • SCD in LV Dysfuction is Uncommon in Indians: Myth or Reality
  • Quality of HF Care in India: Optimal or Time to Wake Up?
  • Discussion and Audience Interaction

10:00 - 11:00

  • Dr. V V Shah Oration
  • Dr B C Roy Memorial Oration-
  • Smt. Uma Rani Banerjea Memorial Oration
  • K K Datey Oration

11:30 - 12:00
Plenary Session

  • Imaging in ACS
  • AICD For Primary Prevention of SCD in Idiopathic DCM: Is it time to rethink?

12:00 - 13:00
Plenary Session

  • Guideline based therapy for Acute and Chronic Heart Failure
  • Role of Catheter Ablation vs Drugs in the Management of Atrial Fibrillation. 
  • Air Pollution and CVD
  • High risk stable CAD patients:How to identify

13:00 - 12:00
Blockbluster Trials of 2018

  • Top trials in interventional cardiology
  • Top trials in preventive cardiology
  • Top trials in Heart failure
  • Top trials in electrophysiology

14:00 - 15:00

  • Choosing Thrombolytics in AMI: Review of Evidence
  • Choice of DAPT : Does it matter?
  • Late Presenters after AMI: When to Intervene?
  • Percutaneous left ventricular assist devices in Cardiogenic shock.
  • Management of Arrhythmias in STEMI
  • Discussion and Audience Interaction

15:00 - 16:00
Key Note Address

  • Long term safety of Statin therapy : Perception versus Evidence.
  • Where does PCI stand today after COURAGE, FREEDOM & ORBITA.
  • Secondary Prevention for RHD 
  • TBA
  • Discussion and Audience Interaction

16:00 - 16:45
SCA: The Nuts and Bolts of Clinical Decision Making

  • Can ECG help in predicting patients at risk for SCD
  • Assessing risk for SCA in LV Dysfunction: Just EF or Should we Look Beyond
  • SCA Risk in HFmrEF and HFpEF: Underecognized, Undertreated?
  • ICD for SCA Prevention: Current Guidelines
  • Discussion and Audience Interaction

16:45 - 17:30
Key Note Address

16.45 - 16.57 Hypertension Targets in Recent Guidelines: What is supported by Evidence?
16.57 - 17.09 PCI of Multi-Vessel Disease in Diabetics - Evidences and Uncertainties
17.09 - 17.21 TBA
17.21 - 17.30 Discussion and Audience Interaction

09:00 - 10:00
CardioDiabetes Symposia

  • Is Type II Diabetes a CAD Risk Equivalent?
  • What to add after Metformin: GLP-1, DPP-4 or SGLT2?
  • SGLT 2 inhibitors - Are they worth the hype?
  • Should Statins and Aspirin be prescribed to all patients with Diabetes?
  • Atherogenic dyslipidemia, Prediabetes and the Metabolic Syndrome : What’s New?
  • Discussion and Audience Interaction

10:00 - 11:00


10:00 - 10:30
STEMI Perspectives
  • STEMI and Multi-vessel Disease: Integrating Evidence into my Practice
  • Pharmacoinvasive approach for all patients who receive thrombolysis: Does it happen in my practice
  • Discussion and Audience Interaction
10:30 - 11:00
Chronic CAD: A Case Based Approach
  • 50 year old male with few cardiovascular risk factors (but not diabetic) presents with stable atypical exertional angina
  • Stress Thallium would be my Investigation of Choice: Knowing Physiology is Always Better
  • CT Angio would my Investigation of Choice: Knowing Anatomy Always Makes More Sense
  • Discussion and Audience Interaction

13:00 - 14:00
Case Based Discussion

13.00 - 13.30 Stable coronary Artery Disease 
    45 year male presented  with Stable Angina on Exertion class II from last 6 months. Non diabetic, BP 145/85, Lipid : LDL-164, HDL-32, TG-266.  
    What furthur investigation and how to risk stratify
    Choice and Optimization of Pharmacotherapy
    When to Perform Angiogram and How to  Intervene
    Discussion and Audience Interaction

13.30 - 14.00  Acute MI
                       45 year male presented  with Chest Pain  since 8 hours in non PCI capable hospital . ECG - STEMI Anterior wall
   How to Proceed? 
   When and How to Refer for Revascularization?
   Discussion and Audience Interaction

14:00 - 15:00
LM & Bifurcation Symposia

  • LM with Mutivessel Disease: Are PCI and CABG Equivalent
  • Imaging for LM: The optimal approach in optimizing outcomes
  • Left main intervention. Tips and ticks.
  • DK Crush, Culotte, SKS, T ot TAP: Which is the best strategy
  • Should Provisional Stenting Be Considered Even in Complex Bifurcations?
  • Discussion and Audience Interaction

15:00 - 16:00
AF Conclace

  • Atrial fibrillation: Pathophysiology & classification.
  • The value of ‘real world’ evidence for assessment of anticoagulation in atrial fibrillation
  • Managing Heart Failure in Patients with Atrial Fibrillation
  • Monitoring for AF in Cryptogenic Stroke: Always Needed?
  • Discussion and Audience Interaction

16:00 - 16:45
Debate : Views and Counterviews

Debate -1 TBA
  • Pro
  • Con
  • Rebuttal
  • Rebuttal
Debate -2 Coronary Revascularisation provides no meaningful clinical benefit over Optimal Medical Therapy in patients with Stable Ischaemic Heart Disease Failure
  • Pro
  • Con
  • Rebuttal
  • Rebuttal

16:45 - 17:30
Cases Which Foxed Me

  • 49 year old male with HCM with chronic AF on OAC, had pat hisory of ischemic stroke. Presents with SAH.
  • Discussion and Audience Interaction
  • 52 year old patient with RHD Moderate MR and AF. What would be the appropriate anticoagulant.
  • Discussion and Audience Interaction
  • 52 year old female post prosthetic MVR 10 years back. Now presents with intermittent SOB, mild pedal edema, NYHA Class II. Echo shows normal prosthetic valve function, EF 60% and severe TR with normal RV function. How to proceed
  • Discussion and Audience Interaction

09:00 - 10:00
RHD: The Forgotten Emperor

  • Burden of RHD in India: Rising? Declining? Just Dont Know?
  • Acute Rheumatic Fever - An Update
  • Should we follow Western guidelines for our RHD patients?
  • PTMC @ 35 years - What have we learned?
  • Valve surgeries in RHD in 2018
  • Discussion and Audience Interaction

10:00 - 11:00

  • Genetics of Cardiomyopathy - Lessons Learnt
  • Diabetic Cardiomyopathy - Is it a Separate Entitiy?
  • Myocarditis - An update
  • Tachy-CMP - Can you ever Miss it?
  • Non Compaction Cardiomyopathy
  • Discussion and Audience Interaction

13:00 - 14:00
Tropical Cardiology - Neglected Diseases

  • Tubercular pericardial diseases
  • Granulomatous myocarditis in India: an update
  • Takayasu Aortoarteritis – a simplified approach to management
  • Kawasaki disease
  • EMF – a disease heading to extinction?
  • Discussion and Audience Interaction

14:00 - 15:00
Diet in Cardiology : Agree to Disagree

  • Carbohydrates: Are they the Main Culprit? 
  • Oil for Indians: Which is the Best?
  • Are Dairy Fats good for Heart?
  • Egg consumption and CAD risk: Any Concerns Left? 
  • Saturated Fat : Friend or Foe?
  • Discussion and Audience Interaction

15:00 - 16:00
Focused Session on Devices

  • The Leadless Pacemaker: Where Will it Fit in Practice?
  • Subcutaneous ICD: The Story Thus Far
  • Wearable Implandable Defibrilator: Where do they bridge the gap?
  • MRI compatible devices: Does my patient need it?
  • Non functional Leads: Abandon or retrieve
  • Discussion and Audience Interaction

16:00 - 16:45
Do These Have Any Role in Primary Prevention?

  • Routine CT Angiogram
  • Routine Stress Test
  • hsCRP
  • ACEI in Medium Risk Patients
  • Routine High Intensity Exercise
  • Flax Seeds & Omega 3 Fatty Acids

16:45 - 17:30
Should We Write An Obituary For

  • Stethoscope
  • IABP
  • BVS
  • Renal Denervation Therapy
  • Thrombosuction
  • Beta Blockers in Hypertension

09:00 - 11:00
Post Graduate Teaching: Session III

  • Approach to Cyanotic congenital heart disease in adults
  • ECG in congenital heart disease
  • Case 2: TOF physiology
  • Case Presenter

13:00 - 16:00
Post Graduate Teaching: Session IV

Bed side Evaluation of Acyanotic Congenital Heart Disease
Case 3: Cyanotic CHD
Case Presenter

Mistakes to avoid in case presentation

Case 4: Miscellaneous
Case Presenter
Spotters Exotica
Meet your examiner

16:00 - 16:45
Preventive Cardiology

  • Fatty Acids and their role in Cardiometabolic Health
  • Smoking and Metabolic Health
  • Why Doctors are More Worried than Excited over E-Cigarettes
  • What can we Learn from Failed Lifestyle Interventions? 
  • Is it in the genes? Genetic determination of exercise effects. 
  • Wine and CVD: Win or Whine
  • Discussion and Audience Interaction

13:00 - 14:00
Oral Poster Presentation

  • A weighted risk score to predict post-PTMC mitral regurgitation using machine learning techniques - observations from a large-volume tertiary care centre in south India.
  • Predictors of restenosis and early re-intervention following successful first percutaneous transseptal mitral commissurotomy(PTMC) during follow-up - data from a tertiary referral care centre in South India
  • Single lead implantable cardioverter-defibrillator lead system with atrial sensing dipole (Dx-aicd technology): 1 year follow up.
  • Atrioventricular nodal reentrant tachycardia with absent retrograde fast pathway conduction in patients – a distinct entity.
  • Reusability of cardiac implantable electronic devices (CIED) devices: long term outcome.
  • Long term follow-up of patients undergoing stenting vs. endarterectomy for carotid artery stenosis – an indian perspective.
  • Transcatheter aortic valve implantation safe and effective (single centre experience of 26 cases).

14:00 - 15:00
Oral Poster Presentation

  • Profile of acute heart failure in a large tertiary care centre in kerala.
  • Prevalence and risk determinants of spontaneous ventricular arrhythmias in patients with non-ischemic systolic heart failure: results from a single centre study.
  • Lung ultrasound evaluation of diabetic patients with acute onset dyspnea and its relation with established markers of heart failure.
  • Role of extra corporeal membrane oxygenation in myocardial dysfunction due to aluminium phosphide poisoning.
  • Circulating cell free DNA, circulating cell free RNA with global longitudinal strain – non invasive early predictor of post heart transplant rejection.
  • Is ARNI exclusive in management of chronic heart failure ? 2 years experience in a central hospital of indian railway.
  • ABSI vs BMI– marker of obesity and its comorbities correlation.

15:00 - 16:00
Oral Poster Presentation

  • Antiplatelets strategies and outcome in cardiac patients undergoing dental implants.
  • Clinical outcomes of patients undergoing primary angioplasty for acute myocardial infarction treated with prasugrel versus ticagrelor at the end of 1 month & 1 year.
  • Cardiac health awareness amongst women presenting for routine health checkup at tertiary care centre : trends over the last 15 years.
  • Study of clinical profile and utility of various tests in patients with syncope.
  • Clinical profile and prognostic significance of right heart thrombi in acute pulmonary embolism -indian perspective.
  • Determinants of in hospital clinical course and outcome in sub massive pulmonary embolism.
  • QRS-T angle: A novel marker for Cardiac Sarcoidosis

16:00 - 16:45
Oral Poster Presentation

  • BACKGROUND: Prevalence of abdominal aortic aneurysm (AAA) has ethnic difference, and Coronary artery disease (CAD) shares several risk factors with abdominal aortic aneurysm (AAA), Sparse Indian data are available on this. We evaluated the prevalence of AAA during transthoracic echocardiography (TTE) and risk factors of AAA in patients with CAD AIMS:To investigate the prevalence of AAA during TTE and the associated risk factors of AAA with CAD patients in north india. MATERIAL AND METHOD: This is a prospective observational study. Study population consists of all the patients with Coronary artery disease (CAD) / Myocardial infraction visiting Department of Cardiology, from 1st January 2017 to 30th November 2017. All the patients with CAD / ACS/MI were included in the study and Patients with AAA due to other etiology were excluded. Screening for an AAA was performed directly at using a echocardiographic 3.5 MHZ cardiac probe. RESULTS: Total no patients screened 526 , AAA was present in 4.8%(25) of CAD patients. Smoking hypertension and hyperlipidaemia were predominant risk factors for AAA in our study but were not statistically significant because same risk factors were also prevalent in the comparison group. Diabetes, peripheral vascular disease and family history were statistically significant risk factors for AAA in our study. The mean sizes of AAA was 3.4mm . CONCLUSION : Presence of AAA is significantly higher among CAD patients. Presence of AAA in CAD patients in North India appears to be less as compared to the western world studies. Coronary artery disease (CAD) shares several risk factors with abdominal aortic aneurysm (AAA). Therefore, opportunistic examination of the abdominal aorta during routine TTE could be effective, way of screening.
  • Abstract: Background: Echocardiographic assessment of LV function generally requires expert echocardiographer and is somewhat subjective and prone to reader discordance. Mitral annular plane systolic excursion (MAPSE) has been suggested as a surrogate measurement for LV function. Objective: We aim to validation MAPSE derived formula to calculate the ejection fraction [where EF = 4.8 X MAPSE (mm) + 5.8] in adult males with left ventricular (LV) dysfunction (using tissue tracking algorithm and M mode method). Methods: This was a prospective observational study which included 200 adult male patients having LV systolic dysfunction (defined as EF < 50% by M mode or modified Simpsons’s rule for EF measurement). EF was calculated by conventional methods like qualitative visual inspection, biplane modified Simpson’s rule and M mode. MAPSE was calculated by tissue tracking algorithm and M mode. MAPSE-derived EF was compared against other conventional methods to measure EF. Results: The study included 200 adult male patients with LV systolic dysfunction, of which 124 (62%) had ischemic cardiomyopathy, while the remaining 76 (38%) had dilated cardiomyopathy. The mean age of the study group was 60.6 ± 9.8 years. The mean EF measured by M-mode was 31.6 ± 6.1% and that measured by modified Simpson’s rule was 28.59 ± 7.01% which was nearly the same by visual inspection. There was a significant positive correlation between average MAPSE and EF measured by M mode (r = 0.554, P < 0.001), EF measured by Simpson’s rule (r = 0.585, P < 0.001), and EF measured by visual inspection (r = 0.611, P < 0.001). Conclusion: Despite routine use of newer and more refined echocardiographic technologies nowadays, such as strain-rate imaging, speckle-tracking imaging, and 3D echocardiography, the use of MAPSE measurement is still helpful to evaluate LV systolic function especially in case of poor sonographic windows with minimal inter- and intra-observer variability. MAPSE-derived EF using the equation EF = 4.8 X MAPSE (mm) + 5.8 is a valid technique in adult males with severely impaired LV systolic function.
  • Background: Left ventricular diastolic dysfunction (LVDD) causes adverse prognosis and outcomes in cardiac patients in multiple ways. We aimed to study demographics of patients with LVDD, stage their level of LVDD and assess the influence of LVDD on immediate perioperative outcomes, morbidity and early mortality in patients undergoing OPCAB.Methods : This retrospective observational study with prospective analysis included 826 patients undergoing elective OPCAB between Jan 1 2010 and Dec 31 2017 whose follow-up s were serially available with reasonable accuracy . LVDD was assessed by transthoracic echocardiography and tissue Doppler imaging. Study cohort was classified into four grades of LVDD; normal ,Grade 1- mild (relaxation abnormality), grade 2 LVDD (pseudo-normal pattern), and grade 3 or severe (restrictive pattern of LVDD ). Study end-points were major adverse cardiac events( MACE)and in-hospital adverse post op events such as -longer need for ventilation,difficult extubation,post op atrial fibrillation and postoperative systolic dysfunction.Follow-up till the last available records evaluated LVEF and new MACE like cardiac death and rehospitalisation for heart failure. Multivariate logistic regression was used to evaluate effect of LVDD on immediate and intermediate-term post-operative outcomes.Results: Of the 826 patients we found:normal diastolic function (n =75, 9.1%), type 1 DD (n =443, 53.6%)( together clubbed as arm A), type 2 DD (n =222, 26.9%), and type 3 DD (n=87, 10.5%)( together as arm B). Operative strategy did not significantly differ between the two arms. Age and systemic hypertension were comparable, however type 2 DM, LVEF /= 33 with diffusely diseased arteries and poor graftablity – were more prevalent in arm B, compared to arm A( p< 0.001), longer time to extubation or need of reintubation (for respiratory or cardiac events) with higher need for antibiotics ,and prolonged hospitalization>10 days(all p < 0.001).Postoperative renal dysfunction (with Sr.creat> 1.5 or > twice the baseline value) was numerically but not significantly higher. Follow-up was available from 26 months to 82 months( mean 57.5 months, median- 52months) with reasonable accuracy of history backed with electronic stored in-hospital data.Multivariate analysis revealed that presence of DM with higher Syntax score, and past h/o MI with preoperative EF < 50% independently predicted higher LVDD , further higher grades of LVDD in turn independently predicted occurrence of immediate post op AF, respiratory complications and longer time to extubation (odds ratio 3.68, 95% CI: 1.84 to 10.36, p =0.01) and prolonged hospitalization with need of higher antibiotics(OR 5.75, 95% CI: 1.84 to 10.36, p =0.01) higher readmissions for heart failure, MACE and post op persistent LV dysfunction at 1 yr
  • Background: 2D echocardiography with doppler has been standard of care for diagnosis of prosthetic heart valve dysfunction. Recent advancement of 3D Echocardiography has allowed improved visualization and assessment of prosthetic valve functions. This study attempts to compare the efficacy of 3D TEE with routine standard of care management. Methods: 50 patients with prosthetic heart valve obstruction and stable hemodynamics were evaluated with 2D and 3D TEE. Leaflet motion, presence or absence of mass, and echo density of mass in form of intensity ratio were evaluated. Patients with obstructed prosthetic valve were evaluated for presence of thrombus or pannus by both 2D and 3D TEE. The diagnostic efficacy of both the modalities were compared. Results: Out of 50 patients, 32 patients had isolated mitral valve prosthesis and 6 patients had isolated aortic valve prosthesis and rest all, 12 patients had dual valve prosthesis. 2D TEE was able to detect thrombus in 2 patients while pannus in none of the patient. Compared to that, 3D TEE was able to detect thrombus in 17 patients (34%) while pannus in 10 patients (20%), which showed significantly higher diagnostic potency of 3D TEE (p values p=0.0004 and p=0.0027 respectively). Though no statistical difference (p>0.05) was observed between both the techniques in case of leaflet movement assessment. Conclusion: 3D TEE is a superior technique for detecting both the mechanisms (thrombus and pannus formation) involved in prosthetic heart valve thrombosis. As newer imaging techniques has made acquisition and reconstruction quite easy, more frequent usage of this sensitive modality should be favored.
  • Background: Severe chronic mitral regurgitation (MR) causes a significant left ventricular (LV) and left atrial (LA) volume overload, leading to LV and LA dilatation. Volume overload caused by mitral regurgitation (MR) is one of the reasons of cardiac remodeling. Progressive left ventricular (LV) and Left atrial (LA)remodeling occurs, and LV dysfunction may insidiously develop in asymptomatic patients. So the present study is conducted To study LA and LV function by 3D speckle tracking and strain analysis in patients with chronic primary Mitral regurgitation (MR) of Rheumatic and degenerative etiology (MVP) and To compare the LA and LV strain patterns in patients with MR and healthy controls. Methods Single center prospective case control study on all patients presenting with organic mitral regurgitation due to rheumatic and mitral valve prolapse with healthy controls for a period of one year in the department of cardiology, Government Medical College, Calicut. The total subject strength was 100 including 50 controls. Trans thoracic 2D and 3D echo cardiography were be performed in the left lateral decubitus position using commercially available ultrasound system Vivid E9 system (GE Healthcare, Horten, Norway).All 2D and 3D measurements were taken for cases and controls. All analysis were carried out using Echo PAC software Apical 4- and 2-chamber view acquisitions were used for longitudinal strain, radial, circumferential and area strain analysis and Apical 4 chamber was used for left atrial longitudinal strain analyses. Results Baseline characteristics were matched.Mean LA dimension was increased with statistically significant values(Chi square-5.814, P-0.015). mean LVIDd was also increased in MR With comparison to controls(Chi-5.83, p=0.036)With comparison to controls. The total patients with impaired global longitudinal Strain(GLS) and global radial strain(GRS)was 72% 26%and was statistically significant(chi-10.28; p=0.01 and 11.61;p=0.001), whereas Global Circumferential strain(GCS) and Global Area Strain(GAS) were in significant (p=0,31 and p=0.15). In LA strain parameters peak LA contractile strain was impaired in 53% of individuals but in MR alteration of LA contractile strain was statistically insignificant(chi-2.05;p=0.15). However LA strain Rate and Strain In reservoir phase was statistically significant(p=0.05). Conclusion LA and LV strain patterns are impaired in chronic severe MR. However LV-GLS, LV-GRS, LA peak contractile strain, LA longitudinal strain rate were significantly impaired in subjects compared to controls

09:00 - 10:00
Anticoagulation: Evolving Practices, Problems and Paradigms

9.00 - 9.12  Anticoagulation Strategies post-PCI in Atrial Fibrillation: New Insights, New Approach
9.12 - 9.24  My patient is Optimally treated on Warfarin : Should I shift to DOACs
9.24 - 9.36  Choosing between DOACs Wisely: Are they all the Same?
9.36 - 9.48  Device Detected AF: Candidate for Anticoagulation?
9.48 - 10.00 Contraindications for DOACs: A Case Based Discussion
Reversing DOACs: Dos and Dont''s
Discussion and Audience Interaction

10:00 - 11:00
Debate : Views and Counterviews

Debate - 1 Statin for All Beyond 40 years?
  • Pro
  • con
  • Rebuttal
  • Rebuttal
Discussion and Chairperson Remarks

Debate - 2
  • Pro
  • con
  • Rebuttal
  • Rebuttal
Discussion and Chairperson Remarks

11:00 - 12:00

  • Approach to a patient with syncope
  • Managing Neurocardiogenic Syncope: Status Update
  • Syncope: My greatest surprise and my worst nightmare
  • Implantable Loop Recorders: Worth the Price?
  • Discussion and Audience Interaction

12:00 - 13:00
Clinical Cardiology: Do We have Definite Answers?

  • Executive cardiac check up – Is it for patient or doctor?
  • Role of viability testing before re-vascularisation in LV Dysfunction: Does it have a role?
  • Which Patient with Cardiac Arrest Should Be Wheeed into the Cath Lab
  • Cardiac patient undergoing non cardiac surgery-Is the patient “Cleared”?
  • Discussion and Audience Interaction

09:00 - 10:00
Awards Session

Prof. D P Basu Memorial Award
CT Virtual Cardiac Dissection: A Novel Method of Enhanced 3D Visualization of Internal Cardiac Anatomy
Prof. D P Basu Memorial Award
A decade of free CRT Implantation - a Powaqqatsi averted !! -Real - world data from Sri Sathya Sai Institute of Higher Medical Sciences Whitefield, Bangalore
Prof. D P Basu Memorial Award
Evaluation of Systemic and Tissue Levels of Cytokines of Th17 Axis and Th1 Axis  In Patients of Chronic Rheumatic Heart Disease: An Observational Study
Prof. D P Basu Memorial Award
Idiopathic outflow-tract ventricular tachycardia: can sinus rhythm electrocardiography help to identify underlying occult cardiac sarcoidosis?
Prof. D P Basu Memorial Award
Correlation of QRS duration with myocardial blush grade as a marker of myocardial reperfusion in primary percutaneous coronary intervention
Prof. D P Basu Memorial Award
Natural History of Reversible Symptomatic Bradyarrythmia- an observational study with long term followup
Modi Mundi Pharma Award
Comparison of immediate and 6-month follow-up results of percutaneous transseptal mitral commissurotomy in patients of rheumatic mitral stenosis in sinus rhythm and atrial fibrillation - An echocardiographic and haemodynamic study

10:00 - 11:00

  • Etiopathogenesis and Classification of PAH
  • PAH Diagnosis: Non Invasive Approach
  • Drug Therapy for Idiopathic PAH: When? For Whom? How?
  • Managing PAH in HFeEF
  • Managing the Adult with Eisenmenger Syndrome: An Update
  • CTEPH - Managemet in 2018
  • Discussion and Audience Interaction

11:00 - 12:00
How to Approach

  • Patient with Asymptomatic Ischemia
  • Suspected myocarditis
  • HF patient not tolerating BB
  • Acute cor pulmonale
  • Ischemic Mitral Regurgitation
  • Discussion and Audience Interaction

12:00 - 13:00
Veno Thrombo- Embolism

  • Deep Vein Thrombosis: When to thrombolyse
  • Acute PE: To Lyse or Not to Lyse
  • Catheter intervention for PE: Better outcomes?
  • IVC Filters: Real Role or An Exercise in Futility
  • Preventing post thrombotic Syndrome: Whats the best strategy
  • Discussion and Audience Interaction

10:00 - 11:00
Pregnancy and Cardiac disease

  • Peripartum Cardiomyopathy
  • Management of valvular heart disease during pregnancy
  • Pregnant patient with Mechanical Valve: Managing Anticoagulation
  • Pregnancy and Congenital Heart Disease
  • A case of pregnant woman with aneurysmal dilatation of aorta 4.4 cm
  • Discussion and Audience Interaction

11:00 - 12:00
Peripheral Vascular Disease

  • Screening for Aortic Aneurysm in high risk individuals
  • Salvaging Critical Limb Ischemia: The right approach
  • Renal Artery Stenosis: When to Intervene
  • Antithrombotic Strategy for peripheral artery thrombosis
  • Varicose Veins: When to Intervene
  • Discussion and Audience Interaction

12:00 - 13:00
Hypertension : Rapid Fire

  • Beta-blockers in Hypertension: Current Status
  • Managing Postural Hypotension in Hypertensive Patients
  • Hypertension in heart failure
  • Iatrogenic Hypertension 
  • Hypertension and renal Failure 
  • Hypertension and sexual dysfunction.
  • Hypertension and RAS: When and How to Treat
  • Discussion and Audience Interaction

Conference Theme: Translating Recent Advances to Regional Needs

© Copyright CSI 2018. All Rights Reserved